HIV AND CANCER TREATMENT - Patent 0954309

(19)

(11)

EP 0 954 309 A1

(12)

(43)	Date of publication:
	10.11.1999 Bulletin 1999/45

(21)	Application number: 97949599.0

(22)	Date of filing: 26.11.1997

(51)

International Patent Classification (IPC):

A61K 9/ 127^{( . )}
A61K 31/ 27^{( . )}
A61K 31/ 343^{( . )}
A61K 31/ 4184^{( . )}
A61K 31/ 427^{( . )}
A61K 45/ 00^{( . )}
A61P 31/ 12^{( . )}
A61P 35/ 00^{( . )}

A61K 31/ 17^{( . )}
A61K 31/ 325^{( . )}
A61K 31/ 41^{( . )}
A61K 31/ 4196^{( . )}
A61K 31/ 662^{( . )}
A61K 45/ 06^{( . )}
A61P 31/ 18^{( . )}

(86)	International application number:
	PCT/US1997/021564

(87)	International publication number:
	WO 1998/051303 (19.11.1998 Gazette 1998/46)

(84)	Designated Contracting States:
	AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE

(30)

Priority:

16.05.1997 US 19970046726P

(71)	Applicant: THE PROCTER & GAMBLE COMPANY
	Cincinnati, Ohio 45202 (US)

(72)	Inventor:
	CAMDEN, James, Berger West Chester, OH 45069 (US)

(74)	Representative: Woof, Victoria
	Procter & Gamble Technical Centers Limited, Lovett House, Lovett Road Staines, Middlesex TW18 3AZ Staines, Middlesex TW18 3AZ (GB)

(54)	HIV AND CANCER TREATMENT